丹纳赫携手ONT开发和商业化自动化的传染病测序工作

动脉网
13 Apr

丹纳赫子公司Cepheid与Oxford Nanopore Technologies合作,开发自动化传染病测序工作流程,用于全基因组测序,可扩展至癌症和人类遗传学等领域。该流程将提供丰富的生物标志物数据,加速关键分子信息获取。财务条款未披露。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10